Gast D R, Horst R L, Jorgensen N A, DeLuca H F
J Dairy Sci. 1979 Jun;62(6):1009-13. doi: 10.3168/jds.S0022-0302(79)83364-0.
Twelve cows, at least third parity, were assigned randomly to either a control or treatment group. Treated cows received .4 mg of the vitamin D metabolite, 1,25-dihydroxycholecalciferol intramusculary in 5 ml corn oil. Intramuscular injections were started 5 days before predicted calving with reinjections every 5 days until calving. Incidence of parturient paresis was 0 and 33% (2 of 6) in the treated and control groups. Response to treatment was rapid with elevated calcium in serum approximately 12 h postinjection. Treatment maintained or elevated calcium and phosphorus concentrations in serum during the critical period, 24 h pre- to 48 h postpartum, when milk fever is most likely to occur. There was, however, no significant difference between treatments at 72 h postpartum. Based on these observations 1,25-dihydroxycholecalciferol holds promise as a preventative of parturient paresis; however, further studies are needed on application and safety.
12头至少处于第三胎次的奶牛被随机分配到对照组或治疗组。治疗组奶牛肌肉注射5毫升玉米油中含有的0.4毫克维生素D代谢物1,25 - 二羟胆钙化醇。在预计产犊前5天开始肌肉注射,每5天重复注射一次,直至产犊。治疗组和对照组中,产乳热的发病率分别为0和33%(6头中有2头)。注射后约12小时血清钙升高,对治疗的反应迅速。在产后24小时至48小时这一最易发生乳热的关键时期,治疗可维持或提高血清钙和磷的浓度。然而,产后72小时时,各治疗组之间无显著差异。基于这些观察结果,1,25 - 二羟胆钙化醇有望作为预防产乳热的药物;然而,在应用和安全性方面还需要进一步研究。